How many insider trades does FilingIQ track for TPST?

FilingIQ tracks 23 Form 4 insider transactions for TPST (Tempest Therapeutics, Inc.), covering filings from Jun 25, 2021 onwards. 3 of those were filed in the last 90 days.

Are TPST insiders net buyers or net sellers?

Across the full Form 4 history for TPST, 7 transactions (30%) were open-market purchases and 2 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TPST insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TPST in?

Tempest Therapeutics, Inc. (TPST) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $23.09M.

TPST insider trading

NasdaqCM Healthcare

Tempest Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

30% / 9%

Market cap

$23.09M

About Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.

Company website: www.tempesttx.com

TPST insider activity at a glance

FilingIQ has scored 23 insider transactions for TPST since Jun 25, 2021. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 7 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TPST insider trades is 68.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TPST trades on FilingIQ Raw filings on SEC EDGAR

Latest TPST Form 4 filings

Angel Matthew CEO and President

P Mar 24, 2026

Brady Stephen R President and CEO

P Jul 3, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading TPST

Angel Matthew

2 trades · score 79.0

Frequently asked

How many insider trades does FilingIQ track for TPST?: FilingIQ tracks 23 Form 4 insider transactions for TPST (Tempest Therapeutics, Inc.), covering filings from Jun 25, 2021 onwards. 3 of those were filed in the last 90 days.
Are TPST insiders net buyers or net sellers?: Across the full Form 4 history for TPST, 7 transactions (30%) were open-market purchases and 2 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TPST insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TPST in?: Tempest Therapeutics, Inc. (TPST) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $23.09M.

Methodology & sources

Every TPST insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.